ライフサイエンスコーパス: microparticle

1 ia, by a vortical flow created by a rotating microparticle.

2 in a high-shear region, in the vicinity of a microparticle.

3 -end regions and to a capture probe-magnetic microparticle.

4 of intricate arrays of droplets, cells, and microparticles.

5 S/DNA NP loading and encapsulation within ZN microparticles.

6 tection of those walkers by substrate-coated microparticles.

7 l molecules delivered through drug-releasing microparticles.

8 ptome, and plasma apoptotic endothelial cell microparticles.

9 /PEI) nanoparticles and loaded into ESTA-MSV microparticles.

10 ASE1L3-sensitive chromatin on the surface of microparticles.

11 of cytokine signaling (SOCS) proteins within microparticles.

12 sis based on a scattering model of spherical microparticles.

13 es up to 1 000 000 times greater than silica microparticles.

14 levated levels of apoptotic endothelial cell microparticles.

15 reen microalga Chlamydomonas reinhardtii, on microparticles.

16 the formation of ceramide and the release of microparticles.

17 evels in plasma, particularly in circulating microparticles.

18 lations, and steam pops produced most of the microparticles.

19 ghest values corresponded to the spray-dried microparticles.

20 ubic composites and hollow eightling-like Cu microparticles.

21 ica was present as an amorphous phase and as microparticles.

22 vity and was partly located on extracellular microparticles.

23 69 mug/mL (MCD) 30 min after insufflation of microparticles.

24 rase, enabling direct amplification from the microparticles.

25 tions of the acoustophoretic response of the microparticles.

26 oscillating shell composed largely of silica microparticles.

27 (TLR) ligands, using biodegradable, polymer microparticles.

28 the formation of ceramide and the release of microparticles.

29 tion, characterization and quantification of microparticles.

30 of substances from individual pure-substance microparticles (14-747 mug) with an average relative sta

31 The microparticles (5-10 mum) were primarily composed of Str

32 protein VEGF-CC152S, using albumin-alginate microparticles, accelerated cardiac lymphangiogenesis in

33 al brush border, and are able to transcytose microparticles across the mucosal barrier to underlying

34 sment of novel and economically manufactured microparticle adjuvants, namely strontium-doped hydroxya

35 We suggest that this membrane-mediated microparticle aggregation is a reason behind reported lo

36 other active components are not required for microparticle aggregation.

37 Orally administered microparticles also included an M-cell targeting ligand,

38 photopolymerization, we fabricate colloidal microparticle analogs of the classic examples of links s

39 increased of circulating endothelial-derived microparticles and a reduction of platelet-endothelial c

40 be used as an effective mechanism to deliver microparticles and antimicrobials inside S. mutans biofi

41 4.7 macrophage cells upon the uptake of both microparticles and B. anthracis Sterne 34F2 spores.

42 ng nodes for the capture and manipulation of microparticles and cells along three mutually orthogonal

43 les real-time functional analysis of sorting microparticles and cells in an inertial microfluidic dev

44 in water-in-water emulsions by encapsulating microparticles and cells.

45 served VWF binding to C1q-positive apoptotic microparticles and cholesterol crystals, as well as incr

46 been proposed to be capable of manipulating microparticles and even cells.

47 Microparticles and immune cells in blood were measured b

48 Understanding interactions between microparticles and lipid membranes is of increasing impo

49 only able to shrink larger elements (such as microparticles and microfibers) into micro/nano-elements

50 dy how a short-ranged adhesive force between microparticles and model lipid membranes causes membrane

51 lease of catalytic DNA walkers from hydrogel microparticles and the detection of those walkers by sub

52 s and specialized for the capture of luminal microparticles and their delivery to underlying immune c

53 hear stress-induced increase in CD31+/CD41b- microparticles, and improved FMD after accounting for th

54 prothrombin time, endothelium-derived CD105-microparticles, and platelet count at admission could pr

55 ated with the elevated levels of endothelial microparticles (annexin V(+)/CD41(-)/CD31(+)), including

56 Poly(lactide-co-glycolide) microparticles approximately 1 mum size were loaded with

57 ring coefficients and contrast factor of the microparticles are determined, and in a sensitivity anal

58 Microparticles are formed in stored pRBCs over time and

59 Microparticles are formed in stored pRBCs over time and

60 The silica microparticles are functionalized with branched polyethy

61 Microparticles are guided to and pushed into microwells

62 e functions and clearance mechanism of these microparticles are incompletely understood.

63 nlinear material characteristics of aluminum microparticles are investigated through precise single p

64 Microparticles are lipid bilayer-enclosed vesicles produ

65 previously reported that endothelial-derived microparticles are relevant biomarkers of sepsis-induced

66 ve which randomly dispersed single cells and microparticles are self-aligned to and retained without

67 the microparticle surface when the magnetic microparticles are transferred to a polymerase chain rea

68 Large-scale microparticle arrays (LSMAs) are key for material scienc

69 crowell-based approach to create large-scale microparticle arrays with complex motifs.

70 on of nanoparticle-labelled antibodies using microparticles as solid support.

71 In this validation cohort, we assess microparticles as surrogates of cell activation to impro

72 t the properties and results of Ac-DEX nano-/microparticles as well as the use of the polymer in othe

73 Thus, extracellular microparticle-associated chromatin is a potential self-a

74 d of healthy individuals contains functional microparticles at the levels that have a procoagulant po

75 on fibres, suggesting that platelet-derived microparticles attach to fibrin.

76 polymeric nanoparticles, wafers, microchips, microparticle-based nanoplatforms and cells-based vector

77 n the development of novel nanoparticle- and microparticle-based therapeutics.

78 of a bioresorbable mineral coating improves microparticle-based transfection of plasmid DNA lipoplex

79 coupled with preconcentration onto nano- or microparticle-based traps prior to analysis for the meas

80 flow-mediated dilation (FMD) and circulating microparticles before and after 20 minutes of experiment

81 ple method for producing donut-shaped starch microparticles by adding ethanol to a heated aqueous slu

82 2O2 formation in aqueous suspensions of FeS2 microparticles by monitoring, in real time, the H2O2 and

83 Deposition of microparticles by neutrophils onto inflamed epithelium:

84 x, Kobe, Japan) and neutrophil-derived CD66b microparticles by prothrombinase assay.

85 Metallic microparticles can acquire remarkable nanoscale morpholo

86 Most interestingly, the directionality of microparticles can be controlled and their speed can be

87 We show that chitosan-coated microparticles can lyse human cells and capture the rele

88 Polymeric microparticles can serve as carriers or sensors to instr

89 The microparticles capture DNA at a pH optimal for PCR (8.5)

90 tic surface reactions can be used to deliver microparticle cargo to specified regions in microchamber

91 on of Rho kinase and shedding of endothelial microparticles carrying miR-503, which transfer miR-503

92 p manipulation method that can rotate single microparticles, cells and organisms.

93 Non-contact precise manipulation of single microparticles, cells, and organisms has attracted consi

94 ere, we fabricate a synthetic cell-mimicking microparticle (CMMP) that recapitulates stem cell functi

95 onal characteristics of EMPs and circulating microparticles (cMPs) released by CS.

96 th poly(lactic-co-glycolic acid)(PLGA)-based microparticles, co-loaded with OVA and CpG (PLGA(OVA + C

97 osphate was approximately 55%, while that of microparticles coated with chitosan/carboxymethylcellulo

98 iency was greater than 95%, and the yield of microparticles coated with chitosan/sodium tripolyphosph

99 hly-textured superhydrophobic electrosprayed microparticle coatings, composed of biodegradable and bi

100 orrelation between the capture level and the microparticles concentration in solution, two calibratio

101 A dispersion of magnetic microparticles confined at the air-liquid interface and

102 een applied to demonstrate that the obtained microparticles consist of a triuranium octoxide phase.

103 The different subpopulations of microparticles could be determined via their capture ont

104 Polystyrene 7 mum microparticles could be separated from 5 mum particles w

105 Thus, vaccine microparticles could trigger humoral as well as cellular

106 Chitosan-Zein Nano-in-Microparticles (CS-ZN-NIMs), consisting of core Chitosan

107 Highly radioactive cesium-rich microparticles (CsMPs) released from the Fukushima Daiic

108 anoparticles (d approximately 12 nm) against microparticles (d approximately 100-200 nm).

109 abled delivery of large permeants, including microparticles, deep into colonic tissue ex vivo.

110 very was found to depend on size, with large microparticles demonstrating negligible clearance from t

111 nce of microparticles, unlike clots from the microparticle-depleted plasma, contain 0.1-0.5-mum size

112 rain injury, small membrane vesicles, called microparticles, disseminate procoagulant factors from th

113 ation capable of controlling the position of microparticles during a trident shaped droplet split.

114 functionalized colloids (fluorescent polymer microparticles, dye-labeled protein on gold nanoparticle

115 drive controlled aggregation of polystyrene microparticles, either through reversible coiled-coil in

116 ated that Cavin-2 is secreted in endothelial microparticles (EMPs) and is required for EMP biogenesis

117 Circulating endothelial microparticles (EMPs) are emerging as biomarkers of chro

118 Endothelial microparticles (EMPs) are endothelium-derived submicron

119 Here we combined biodegradable microparticles encapsulating Rapa (Rapa MPs) with vaccin

120 ATRA-PLLA microparticles exerted its efficacy likely through degra

121 The microparticles exhibited a higher gelatinization tempera

122 sion of topically applied gold-coated silica microparticles exhibiting plasmon resonance with strong

123 Indeed, EVs (a terminology that encompasses microparticles, exosomes, and apoptotic bodies) are emer

124 venous-, and lung-specific markers, but not microparticles expressing CD62(+).

125 nical models, we investigated whether plasma microparticles expressing Tissue Factor (TF) are increas

126 As microparticles expressing Tissue Factor (TF) can contrib

127 The microparticles facilitate the simultaneous incorporation

128 MIP layer grafted from the surface of silica microparticles following a RAFT (reversible addition-fra

129 We studied the significance of blood microparticles for fibrin formation, structure, and susc

130 gradable bilayer MN arrays containing nano - microparticles for targeted and sustained intradermal dr

131 hesis, aptly designed for the formulation of microparticles for vaccines and immune modulation.

132 The ATPS based microparticle formation demonstrated in this study, serv

133 fective phosphatidylserine (PS) exposure and microparticle formation, and is linked to mutations in t

134 sponses in vivo was compared with other PNSN microparticle formulations as well as with poly(lactic-c

135 licable to a broad range of nanoparticle and microparticle formulations requiring no additional exper

136 Procoagulant microparticles from endothelial cells and leukocytes ref

137 ired ballooning, procoagulant spreading, and microparticle generation, and it also diminished local t

138 the antigen-presenting cell-targeting glucan microparticle (GP) vaccine delivery system.

139 alysis demonstrated the association of CD105-microparticles (> 0.60 nM eq.

140 ATRA-PLLA microparticles had good biocompatibility, and significan

141 hape and irregular size, and the lyophilized microparticles had irregular shape and size.

142 The atomized microparticles had spherical shape and irregular size, a

143 ively parallel trapping of more than 100,000 microparticles has been demonstrated in high conductivit

144 in films of a composite of nafion and carbon microparticles have been deposited on nonconducting subs

145 Vs (that comprise exosomes and microvesicles/microparticles) have a size ranging from 40 nm to 1 mum

146 technique and mesenchymal stem cell-derived microparticles, have also been studied.

147 Microparticle image velocimetry allowed mapping of the f

148 speed of the microdroplets is measured using microparticle image velocimetry.

149 d reference test (Architect chemiluminescent microparticle immunoassay).

150 Understanding high-velocity microparticle impact is essential for many fields, from

151 A controlled motion of electrically neutral microparticles in a conductive liquid at high temperatur

152 of hybrid composites, which contained glass microparticles in addition to the nanoparticles.

153 hat exploits electrochemical sintering of Zn microparticles in aqueous solutions at room temperature.

154 ulose and to assess the performance of these microparticles in food systems by analyzing their releas

155 Despite the importance of circulating microparticles in haemostasis and thrombosis, there is l

156 Evalution, based on novel digitally encoded microparticles in microfluidic channels.

157 The directed transport of microparticles in microfluidic devices is vital for effi

158 ind reported long retention times of polymer microparticles in organisms.

159 Here we show dynamic generation of tumour microparticles in shear flow in the capillaries within m

160 ith sufficient spatial resolution to resolve microparticles in tablets is essential to ensure high qu

161 Polymer breakdown and movement of microparticles in the eye may limit development of parti

162 sites composed of various loadings of BaTiO3 microparticles in the polymer acrylonitrile butadiene st

163 The uptake of labeled microparticles in the presence of protein S and Gas6 in

164 release of several drugs from various-sized microparticles in vitro and in vivo.

165 of endothelial cell apoptosis (CD31+/CD41b- microparticles) in COPD patients, but not age-matched co

166 logy using micron-scale ellipsoidal magnetic microparticles, in both cases using light-sheet fluoresc

167 s undergo phenotypic changes associated with microparticle ingestion, a consistently sparse populatio

168 ing pro-inflammatory effector T cells, these microparticles inhibited destructive hypersensitivity re

169 However, incorporating microparticles into tissues for in vitro assays remains

170 ontrolled on-demand assembly of colloids and microparticles into various static and dynamic structure

171 The density of the microparticles is determined by using a neutrally buoyan

172 on, and from this the compressibility of the microparticles is inferred.

173 Transfusion of aged pRBCs or microparticles isolated from aged blood into mice caused

174 Transfusion of aged pRBCs or microparticles isolated from aged blood into mice caused

175 in mice receiving transfusions of pRBCs and microparticles isolated from these units.

176 in mice receiving transfusions of pRBCs and microparticles isolated from these units.

177 CS exposure was sufficient to increase microparticle levels in plasma of humans and mice, and i

178 itosan chloride and methyl-beta-cyclodextrin microparticles loaded with DFO (DCH and MCD, respectivel

179 ine hydrochloride)-functionalized CaCO3 core microparticles, loaded with the different loads, that af

180 vivo, of antigen and adjuvant co-loaded into microparticles made from a novel diaminosulfide polymer,

181 Thus, microparticles made from poly(diaminosulfide)-based macr

182 cade to become a promising tool for cell and microparticle manipulation.

183 In the presence of these mineral-coated microparticles (MCMs), we observed up to 4-fold increase

184 data supported our hypothesis that ESTA-MSV microparticle-mediated delivery of miR-146a/-181b amelio

185 namics of Vibrio crassostreae on polystyrene microparticles (micro-PS) using electronic and fluoresce

186 mulation of anti-cancer drugs, and ATRA-PLLA microparticles might be a promising targeted drug for HC

187 Megakaryocytic microparticles (MkMPs), the most abundant MPs in circula

188 relies on the movement of Pt-black/Ti Janus microparticle motors in a solution of sodium borohydride

189 fectors have been proposed, including plasma microparticles (MP).

190 the effects of a single freeze/thaw cycle on microparticles (MPs) and miRNA levels, and show that a s

191 Microparticles (MPs) are cell-cell communication vesicle

192 Circulating microparticles (MPs) are major mediators in cardiovascul

193 Blood microparticles (MPs) are small membrane vesicles (50-100

194 Microparticles (MPs) are submicron-sized shed membrane v

195 During cell death/activation, microparticles (MPs) can be released to the circulation.

196 igated the concept that erythrocyte membrane microparticles (MPs) concentrate cell-free heme in human

197 omaterials, poly(lactide-co-glycolide; PLGA) microparticles (MPs) encapsulating denatured insulin (ke

198 Microparticles (MPs) have emerged as a surrogate marker

199 Most of the plasma mtDNA was contained in microparticles (MPs) of hepatocyte origin, and removal o

200 itive acetalated dextran (Ace-DEX) polymeric microparticles (MPs) which passively target antigen-pres

201 ng concentration of procoagulant endothelial microparticles (MPs), leading to a prothrombotic state,

202 -deleted mice, which had reduced circulating microparticles (MPs), supported accelerated tumor growth

203 nerating extracellular vesicles (EVs) called microparticles (MPs).

204 llular thiol pathway-dependent, procoagulant microparticles (MPs).

205 uorescence light was correlated to the CD66b microparticles/neutrophil count, a surrogate of neutroph

206 drug (vitamin D3, VD3)-loaded PLGA nano- and microparticles (NMP) were prepared by a single emulsion

207 that it depends neither on the nature of the microparticles nor that of the excitation; rather, angul

208 5-microparticles (odds ratio, 2.13) and CD31-microparticles (odds ratio, 0.65) (p < 0.05).

209 isseminated intravascular coagulation: CD105-microparticles (odds ratio, 2.13) and CD31-microparticle

210 um solubility from individual pure substance microparticles of as little as 14 mug in initial mass, i

211 The stability of microparticles of Bordo grape skin aqueous extract, prod

212 ty, possibly due to the presence of nano- or microparticles of elemental Se.

213 Ligand-conjugated microparticles of iron oxide (MPIO) have the potential t

214 netic resonance imaging using antibody-based microparticles of iron oxide targeting P-selectin.

215 The delivery system is based on microparticles of PolyActive hydrogel co-polymer.

216 e effects of naturally produced cell-derived microparticles on fibrin clot formation and its properti

217 e of structure, surface area and porosity of microparticles on the catalytic properties of immobilize

218 ttachment to free isocyanate groups from PUU microparticles, or by physical adsorption of enzyme onto

219 As) and retaining activity upon release from microparticles over 12months in vitro.

220 nd create injectable pulsatile drug-delivery microparticles, pH sensors, and 3D microfluidic devices

221 Polymer hollow microparticles (PHMs) are thin-walled, hollow polymer mi

222 ines levels, circulating endothelial-derived microparticles, platelet-endothelial cell adhesion molec

223 m whereby deposition of PMN membrane-derived microparticles (PMN-MPs) onto intestinal epithelial cell

224 Platelet-derived microparticles (PMPs) are associated with enhancement of

225 Platelet-derived microparticles (PMPs) are involved in hemostasis and vas

226 n, platelets release plasma membrane-derived microparticles (PMPs) exposing phosphatidylserine on the

227 FM) to quantify and qualify platelet-derived microparticles (PMPs), on the whole nano-to micro-meter

228 Endothelial microparticles prevent lipid-induced endothelial damage

229 Microparticles produced using Arabic and cashew gums sho

230 Microparticles produced using cashew gum were more hygro

231 allows a high level of structural control in microparticle production but at the expense of limited p

232 elinase activity, ceramide accumulation, and microparticle production during pRBC storage.

233 elinase activity, ceramide accumulation, and microparticle production during pRBC storage.

234 Here, the authors show that VEGF-immobilized microparticles prolong survival of endothelial progenito

235 s a novel mechanism whereby membrane-derived microparticles released by tissue infiltrating PMNs (PMN

236 s uniquely capable of digesting chromatin in microparticles released from apoptotic cells.

237 Microparticles released functional dual dAb in rabbit an

238 er than dispersing under flow, many of these microparticles remain attached to the lung vasculature o

239 Many applications of nano- and microparticles require molecular functionalization.

240 n to rats of 200 mug DFO encapsulated in the microparticles resulted in its uptake into the cerebrosp

241 in venules, generated tissue factor-bearing microparticles, shortened plasma-clotting times, and inc

242 Thus, the chitosan/xanthan microparticles showed the best potential for practical a

243 In this case, the chitosan/pectin microparticles showed the best release profile.

244 Moreover ATRA-PLLA microparticles significantly enhanced the efficacy of AT

245 Quininib-HA microparticles significantly inhibited RVP in Brown Norw

246 The PEI-decorated silica microparticles (SiO2@PEI MPs) were characterized using s

247 e conjugated to discoidal silicon mesoporous microparticles (SMP) to enhance accumulation of these ag

248 The microparticles spontaneously sequester molecular dyes, f

249 es either formed a core-shell or a composite microparticle structure.

250 in Pluronic F127/dextran ATPS, forms unique microparticle structures due to ATPS guided-self assembl

251 molecules could penetrate easier within the microparticles, substantially increased their solubility

252 sing carboxylic acid-functionalized magnetic microparticles supported onto screen-printed carbon elec

253 bound DNA can be amplified directly from the microparticle surface when the magnetic microparticles a

254 immobilization of fluorescent labels on the microparticle surface.

255 olecules were not conjugated to large, solid microparticle surfaces.

256 hybridization to drive walking on DNA-coated microparticle surfaces.

257 ection process that involves centrifuging of microparticles suspended in different density solutions,

258 onto novel porous poly(urethane urea) (PUU) microparticles synthesized from poly(vinyl alcohol) and

259 e assemblies of the ever-increasing range of microparticle systems.Self-assembled systems are normall

260 esses, and they are able to release membrane microparticles that can transport inflammatory cargo to

261 , radiolabelled molecules, nanoparticles, or microparticles that either naturally accumulate in or ar

262 e a simpler approach using magnetic chitosan microparticles that interact with DNA in a manner that h

263 ing method using amine-functionalized silica microparticles that is effective under varying operating

264 blood filters in the circulation loop showed microparticles (thrombus/coagulum and tissue).

265 e report a strategy for using magnetic Janus microparticles to control the stimulation of T cell sign

266 s can be used for the selective targeting of microparticles to infected tissue(s).

267 Furthermore, CD11a-microparticles to leukocyte ratio evidenced leukocyte ac

268 the acoustic forces direct the encapsulated microparticles to the center of the droplets.

269 cted epithelial self-organization to deliver microparticles to the lumen of reconstituted human intes

270 Here we show that the effectiveness of microparticle transport can be dramatically enhanced by

271 aqueous suspension of silver orthophosphate microparticles under UV illumination, in the presence of

272 In addition, clots formed in the presence of microparticles, unlike clots from the microparticle-depl

273 -survival approach based on VEGF-immobilized microparticles (VEGF-MPs).

274 suspensions is measured as a function of the microparticle volume fraction, and from this the compres

275 The average size of microparticles was 14.1+/-0.3mum with holes of an averag

276 estradiol from the drug-polyketal conjugate microparticles was acid-responsive, as evidenced by fast

277 Tissue reaction to the microparticles was benign in vivo.

278 The average diameter of resistant starch microparticles was in the range of 45.53-49.29mum.

279 The crystalline arrangement of the microparticles was of a V-type single helix.

280 The vaccine microparticles were administered to C57BL/6 female mice

281 The obtained microparticles were analysed by SEM, XRD and DSC.

282 odel confirmed that endothelial cell-derived microparticles were associated with disseminated intrava

283 ol)-poly(lactic-co-glycolic acid) (PEG-PLGA) microparticles were engineered to release TGF-beta1, Rap

284 Protein microparticles were formed through emulsification of 25%

285 d leukocyte-derived circulating procoagulant microparticles were isolated and quantified by prothromb

286 Microparticles were prepared from the estradiol-polyketa

287 The donut-shaped microparticles were stable for more than 18months and ca

288 vinyl-2-pyrrolidone) (P(IA-co-NVP)) hydrogel microparticles were tested in vitro with model proteins

289 yphosphate (TPP), further encapsulated in ZN microparticles, were formulated using a water-in-oil emu

290 ked clusters using thermally expandable soft microparticles, whereby the self-assembling process is r

291 1 directly and as a component of circulating microparticles, which activated synovial fibroblasts in

292 osphate, neutrophil extracellular traps, and microparticles, which have been shown to contribute to t

293 suring the stiffness of cross-linked dextran microparticles, which yielded reasonable agreement with

294 e show that when using P(IA-co-NVP) hydrogel microparticles with 3 mol% tetra(ethylene glycol) dimeth

295 sing commercially available polystyrene (PS) microparticles with a size comparable to cancer cells.

296 le material for the development of probiotic microparticles with adequate physicochemical properties

297 we show an unusual phenomenon that tin (Sn) microparticles with both poor size distribution and spat

298 Microparticles with complex 3D shape and composition are

299 duce poly(lactide-co-glycolide) (PLGA) based microparticles with varying morphologies, and temperatur

300 in largely uniform poly L-lactic acid (PLLA) microparticles, with the efficiency of 91.4% and yield o